---
$id: https://graph.org.ai/products/commodity/51111603
$type: Product
source: UNSPSC
code: "51111603"
title: "Floxuridine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Floxuridine

**UNSPSC Code**: 51111603
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C9H11FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 039LU44I5M, chemically known as uridine, 2-deoxy-5-fluoro- but generally known as floxuridine, which bears US NIH Compound Identifier 3363. European Medicines Agency schedules Floxuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07659MIG. The term FLOXURIDINE is an International Non-Proprietary Name. FLOXURIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule floxuridine under HS 29349990 and SITC 51579. As of Q4 2014, FLOXURIDINE remains the US FDA Preferred Term for this commodity. Floxuridine bears US NLM identifiers UMLS ID C0947603 and NCI Concept Code C504. SMILES: FC1CN(C2OC(C(O)C2)CO)C(=O)[NH]C1=O.

